Metraipolis › archive › dc_ffe0dd3a980f

Overcoming Chemotherapy Resistance in Triple-Negative Breast Cancer with Nanocarrier-Delivered siRNA Therapeutics — Europe PMC PMID:41899235

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41899235
DOI
10.3390/jcm15062311
License (as archived)
solo-consultazione
Archived
2026-11-04T07:29:50.572Z
SHA-256 of the archived text
d5cbf78019afa830a9466d7935e48e821bca1cfde954195b7c759c535cf6fbdf
Stable URL of this page
https://metraipolis.com/documento/dc_ffe0dd3a980f

How to cite

Overcoming Chemotherapy Resistance in Triple-Negative Breast Cancer with Nanocarrier-Delivered siRNA Therapeutics — Europe PMC PMID:41899235 — Europe PMC (en), https://europepmc.org/article/MED/41899235 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ffe0dd3a980f (Metraipolis archive dc_ffe0dd3a980f, sha256 d5cbf78019afa830a9466d7935e48e821bca1cfde954195b7c759c535cf6fbdf)
BibTeX
@misc{dcffe0dd3a980f,
  title = {Overcoming Chemotherapy Resistance in Triple-Negative Breast Cancer with Nanocarrier-Delivered siRNA Therapeutics — Europe PMC PMID:41899235},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41899235},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ffe0dd3a980f; sha256 d5cbf78019afa830a9466d7935e48e821bca1cfde954195b7c759c535cf6fbdf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41899235. Agents can read the archived copy with the MCP tool read_document.